|
2025
|
Invention
|
Controlled-release pth compound.
The present invention relates to a pharmaceutical composition c... |
|
2024
|
Invention
|
Pth prodrugs.
The present invention relates to PTH prodrugs, pharmaceutical compositions compris... |
|
|
Invention
|
Pth treatment of chronic kidney disease. The present invention relates to a PTH compound for use ... |
|
|
Invention
|
Controlled-release pth compound. The invention provides a method of treating or controlling hypop... |
|
2023
|
Invention
|
Pth treatment regimen comprising two pth compounds. The present invention relates to a PTH compou... |
|
|
Invention
|
Pth treatment regimen comprising two pth compounds |
|
|
Invention
|
Pth compounds with low peak-to-trough ratios.
The present invention relates to a pharmaceutical ... |
|
|
Invention
|
Pth prodrugs. The present invention relates to PTH prodrugs, pharmaceutical compositions comprisi... |
|
|
Invention
|
Controlled-release pth compound. The present invention relates to a controlled-release parathyroi... |
|
|
Invention
|
Dosage regimen for a controlled-release pth compound.
The present invention relates to a pharmac... |
|
2022
|
Invention
|
Pth compounds with low peak-to-trough ratios. The present invention relates to a pharmaceutical c... |
|
|
Invention
|
Long-acting pth compound treatments.
The present invention relates to a long-acting PTH compound... |
|
|
Invention
|
Long-acting pth compound treatments. The present invention relates to a long-acting PTH compound ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
hypoparathyroidism; pharmaceutical preparations... |
|
2021
|
Invention
|
Improvement of physical and mental well-being of patients with hypoparathyroidism.
The present i... |
|
|
Invention
|
Improvement of physical and mental well-being of patients with hypoparathyroidism. The present in... |
|
|
Invention
|
Hypoparathyroidism treatment.
The present invention relates to a PTH compound for use in the tre... |
|
|
Invention
|
Hypoparathyroidism treatment. The present invention relates to a PTH compound for use in the trea... |
|
2020
|
G/S
|
Pharmaceutical preparations for the treatment of hypoparathyroidism; Pharmaceutical preparations ... |
|
|
Invention
|
Liquid pharmaceutical formulations of pth conjugates. A liquid pharmaceutical formulation, wherei... |
|
2019
|
Invention
|
Starting dose of pth conjugates.
The present invention relates to a PTH conjugate, in which a PT... |
|
|
Invention
|
Starting dose of pth conjugates. The present invention relates to a PTH conjugate, in which a PTH... |
|
2017
|
Invention
|
Dosage regimen for a controlled-release pth compound. The present invention relates to a pharmace... |
|
|
Invention
|
Incremental dose finding in controlled-release pth compounds. The present invention relates to ph... |
